Is Essa Pharma Inc (NASDAQ: EPIX) The Best Stock To Invest In?

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

Essa Pharma Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $10.45 and fluctuated between $10.97 as its day high and $9.54 as its day low. The current market capitalization of Essa Pharma Inc is $217.78M. A total of 0.54 million shares were traded on the day, compared to an average of 134.85K shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, EPIX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 4 BUYs and 0 SELLs from insiders. Insiders purchased 152,942 shares during that period but sold 0.

In the most recent transaction, Virsik Peter sold 72,782 shares of EPIX for 10.29 per share on Feb 06. After the transaction, the Chief Operating Officer now owns 13,328 company shares. In a previous transaction on Feb 05, Virsik Peter sold 1,194 shares at 9.58 per share. EPIX shares that Chief Operating Officer owns now total 13,328.

Among the insiders who sold shares, Virsik Peter disposed of 1,718 shares on Jan 16 at a per-share price of $10.01. This resulted in the Chief Operating Officer holding 14,022 shares of EPIX after the transaction. In another insider transaction, Virsik Peter sold 699 shares at $6.11 per share on Jan 05. Company shares held by the Chief Operating Officer now total 14,022.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for EPIX in the last 3 months, the mean price target is $19.00 with high estimates of $29.00 and low estimates of $15.00. In terms of 52-week highs and lows, EPIX has a high of $11.67 and a low of $2.56.

As of this writing, EPIX has an earnings estimate of -$0.17 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.15 per share and a lower estimate of -$0.2. The company reported an EPS of -$0.17 in the last quarter, which was 10.50% higher than expectations of -$0.19.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. EPIX’s latest balance sheet shows that the firm has $194.93M in Cash & Short Term Investments as of fiscal 2021. There were $330.97k in debt and $3.93M in liabilities at the time. Its Book Value Per Share was $3.30, while its Total Shareholder’s Equity was $194.01M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EPIX is Buy with a score of 5.00.

Most Popular

Related Posts